These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 19076162
1. Angiotensin-converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumour necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 in rats with type 2 diabetes. Zhang X, Li ZZ, Liu DF, Xu X, Mei ZC, Shen W. Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):631-6. PubMed ID: 19076162 [Abstract] [Full Text] [Related]
2. High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: comparison with non drinkers suffering from similar hepatopathy. Stejskal D, Růzicka V, Fanfrdlová G, Kolár V, Bartek J. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):93-9. PubMed ID: 16170395 [Abstract] [Full Text] [Related]
3. Effects of probucol on hepatic tumor necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 expression in diabetic rats. Zhang X, Li Z, Liu D, Xu X, Shen W, Mei Z. J Gastroenterol Hepatol; 2009 Jun; 24(6):1058-63. PubMed ID: 19220660 [Abstract] [Full Text] [Related]
4. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients. Navarro JF, Mora C, Gómez M, Muros M, López-Aguilar C, García J. Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088 [Abstract] [Full Text] [Related]
5. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Navarro JF, Milena FJ, Mora C, León C, García J. Am J Nephrol; 2006 Mar; 26(6):562-70. PubMed ID: 17167242 [Abstract] [Full Text] [Related]
6. [Effects of escharectomy during shock stage on tissue high mobility group box-1 expression and balance of pro-/anti-inflammatory response in rats after severe thermal injury]. Wang ZT, Yao YM, Sheng ZY, Yu Y, Yang HM, Wang Q, Liu Q, Qiao L, Zhou G. Zhonghua Wai Ke Za Zhi; 2004 Jul 22; 42(14):839-44. PubMed ID: 15363270 [Abstract] [Full Text] [Related]
7. [The role of adiponectin and adiponectin receptor 2 in the pathology of fatty liver]. Li HS, Feng Q, Hu YY, Chen SD, Peng JH, Li XM, Xu LL. Zhonghua Gan Zang Bing Za Zhi; 2009 Nov 22; 17(11):826-30. PubMed ID: 19958641 [Abstract] [Full Text] [Related]
8. [Effect of peroxisome proliferator-activated receptor-alpha agonist on adipokines expression in rats fed with high-fat diet]. Li Y, Huang B, Cheng H, Liang Z, Liu SY. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec 22; 28(6):761-5. PubMed ID: 17260462 [Abstract] [Full Text] [Related]
9. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients. Durante-Mangoni E, Zampino R, Marrone A, Tripodi MF, Rinaldi L, Restivo L, Cioffi M, Ruggiero G, Adinolfi LE. Aliment Pharmacol Ther; 2006 Nov 01; 24(9):1349-57. PubMed ID: 17059516 [Abstract] [Full Text] [Related]
10. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG. Hepatology; 1997 Dec 01; 26(6):1530-7. PubMed ID: 9397994 [Abstract] [Full Text] [Related]
11. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Eur Cytokine Netw; 2006 Mar 01; 17(1):4-12. PubMed ID: 16613757 [Abstract] [Full Text] [Related]
12. [Effects of Qushi Huayu Decoction on cathepsin B and tumor necrosis factor-alpha expression in rats with non-alcoholic steatohepatitis]. Zhang H, Feng Q, Li HS, Chen SD, Wang XN, Peng JH, Zhang N, Hu YY. Zhong Xi Yi Jie He Xue Bao; 2008 Sep 01; 6(9):928-33. PubMed ID: 18782536 [Abstract] [Full Text] [Related]
13. Glycine increases mRNA adiponectin and diminishes pro-inflammatory adipokines expression in 3T3-L1 cells. Garcia-Macedo R, Sanchez-Muñoz F, Almanza-Perez JC, Duran-Reyes G, Alarcon-Aguilar F, Cruz M. Eur J Pharmacol; 2008 Jun 10; 587(1-3):317-21. PubMed ID: 18499099 [Abstract] [Full Text] [Related]
14. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats. Choi KC, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH, Choi KM. Biochem Biophys Res Commun; 2005 Oct 28; 336(3):747-53. PubMed ID: 16157299 [Abstract] [Full Text] [Related]
15. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction. Nyström T, Nygren A, Sjöholm A. Clin Sci (Lond); 2006 Jun 28; 110(6):673-81. PubMed ID: 16466346 [Abstract] [Full Text] [Related]
16. The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats. Liu S, Wu HJ, Zhang ZQ, Chen Q, Liu B, Wu JP, Zhu L. Eur J Pharmacol; 2011 Jan 10; 650(1):384-9. PubMed ID: 20965162 [Abstract] [Full Text] [Related]
17. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese. Wong VW, Wong GL, Yu J, Choi PC, Chan AW, Chan HY, Chu ES, Cheng AS, Chim AM, Chan FK, Sung JJ, Chan HL. Am J Gastroenterol; 2010 Jan 10; 105(1):132-8. PubMed ID: 19809411 [Abstract] [Full Text] [Related]
18. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. Kim HJ, Kang ES, Kim DJ, Kim SH, Ahn CW, Cha BS, Nam M, Chung CH, Lee KW, Nam CM, Lee HC. Clin Endocrinol (Oxf); 2007 Feb 10; 66(2):282-9. PubMed ID: 17224000 [Abstract] [Full Text] [Related]
19. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs. Shen X, Li H, Li W, Wu X, Ding X. Mol Cell Endocrinol; 2012 Nov 05; 363(1-2):27-35. PubMed ID: 22820128 [Abstract] [Full Text] [Related]
20. The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice. Pinto Lde F, Compri CM, Fornari JV, Bartchewsky W, Cintra DE, Trevisan M, Carvalho Pde O, Ribeiro ML, Velloso LA, Saad MJ, Pedrazzoli J, Gambero A. Liver Int; 2010 Apr 05; 30(4):603-10. PubMed ID: 20088867 [Abstract] [Full Text] [Related] Page: [Next] [New Search]